See Today's Golden Star Stocks 🔥 Free for 7 Days See Today's Golden Star Stocks 🔥 Free for 7 Days
News Digest / Lukas Schmidt

Author: Lukas Schmidt
09:15am, Wednesday, Apr 16, 2025
Abbott Laboratories Charts Path to Growth with $500 Million U.S. Investment Amid Tariff Challenges
Abbott Laboratories (NYSE: ABT) plans to invest $500 million in U.S. operations amidst tariff challenges, maintaining a profit outlook of $5.05 to $5.25 per share. Strong Q1 sales, especially in glucose monitors, highlight potential growth opportunities for traders.
Read More